Oak medical research
Back to All Reviews
Investigation Report

Oak Tirzepatide Review

Oak Longevity, oaklovesyou.com, Oak Weight Loss, Oak Longevity Holdings Corp

Also spelled as Oak Longevity, oaklovesyou.com, Oak Weight Loss, Oak Longevity Holdings Corp — Same brand, same great service!

Our investigation of Compounded Tirzepatide from Oak

Under Watch
Some concerns noted, proceed with caution
7.5/10
Good
Rank#102 of 107
Visit Oak
FDA-approved medications
Under Watch

Semaglutide from $119/mo; tirzepatide from $185/mo—flat all-dosage, no subscription

Visit Site
100+
Hours Researched
6
Verified Pros
6
Issues Found
7.5
Final Score

Investigation Overview

Oak consultation process
Oak—found at oaklovesyou.com under the Oak Longevity brand—is a newer cash-pay GLP-1 telehealth service whose pitch is pricing simplicity: one price at every dosage, no subscription, no membership fees. Our research (checked July 25, 2026) verified genuinely consumer-friendly pricing mechanics alongside a thin early record and company details that need clarifying before you pay.

The Flat-Price, No-Subscription Model

Verified from Oak's pages as of July 2026:
  • Compounded semaglutide—as low as $119/month (independent coverage cites ~$130 depending on plan)
  • Compounded tirzepatide—as low as $185/month (~$199 per independent coverage)
  • $200 new-patient offer advertised; free shipping and free health coaching on every plan
  • Also offered: NAD+, glutathione, tadalafil, and sermorelin peptides
Two mechanics stand out favorably: the price stays flat across all dosages (no titration price creep), and Oak advertises "no subscriptions"—you're not locked into auto-renewal by default, which sidesteps the cancellation-friction complaints that plague much of this category. Approval is same-day with no video call required—convenient, though questionnaire-only prescribing puts the screening weight on your honest intake.

What to Clarify Before Paying

Oak's public pages carry a phone number (435-244-7757) and a LegitScript badge, but no physical address, no email, no named physicians, no named pharmacies (just "licensed U.S. compounding pharmacies"), and no published refund policy. Its legal footer references multiple entities—Oak Longevity Holdings Corp., Flow Longevity Holdings Corp., and Mito Health Holdings Corp.—an unexplained structure worth a direct question. Its self-reported patient counts are also inconsistent ("10,000+ satisfied patients" and "trusted by 5,000+ members" appear on the same site). None of this is disqualifying for a 2026-launched brand, but ask: which entity bills you, which pharmacy fills your prescription, and what the refund terms are—in writing.

Early Independent Record

Oak's Trustpilot profile is real but thin: roughly 4.0 stars across about 46 reviews as of July 2026. Individual reviews praise the quick application, fast delivery, pricing, and results; the volume is too small for firm conclusions in either direction. Check the live profile as it grows.

Critical 2026 Regulatory Context

In 2026 the FDA proposed excluding semaglutide and tirzepatide from the 503B bulks list, restricting mass GLP-1 compounding. Confirm current availability and sourcing before enrolling.

Important: Compounded Medications

Oak's compounded semaglutide and tirzepatide are not Ozempic, Wegovy, Mounjaro, or Zepbound. Compounded medications are not FDA-approved finished drug products and have not been reviewed by the FDA for safety, effectiveness, or quality. Consult your own physician before starting.

Our Investigation Summary

Our research (July 25, 2026) found Oak to be a competitively priced newcomer with genuinely consumer-friendly mechanics: compounded semaglutide from $119/month and tirzepatide from $185/month, flat at every dosage, with no subscription or membership fees, free shipping, free health coaching, and a $200 new-patient offer—plus NAD+, glutathione, tadalafil, and sermorelin. A phone line and LegitScript badge are published. Key considerations: no address, email, named physicians, named pharmacies, or refund policy on the public pages; an unexplained multi-entity corporate footer (Oak/Flow/Mito Longevity Holdings); inconsistent self-reported patient counts; questionnaire-only same-day prescribing; and a thin ~4.0-star, ~46-review Trustpilot record. Best for cash-pay buyers drawn to flat no-subscription pricing who confirm the billing entity, pharmacy, and refund terms in writing first.

How Oak Works

1

Answer the online health questionnaire—same-day approval is advertised, with no video call required

2

A licensed doctor reviews your information and prescribes if appropriate

3

Choose compounded semaglutide or tirzepatide at the flat all-dosage price—no subscription enrollment

4

Medication ships free from licensed U.S. compounding pharmacies

5

Use the included free health coaching; reorder as needed rather than auto-renewing

6

Before paying: confirm which entity bills you, which pharmacy fills your prescription, and the refund terms—none are published

What We Found

What's Good

  • Flat one-price-all-dosages model—no titration price creep
  • No subscription or membership—sidesteps auto-renewal cancellation traps
  • Competitive pricing: semaglutide from $119/month, tirzepatide from $185/month
  • Free shipping and free health coaching included
  • Published phone line and LegitScript badge
  • Same-day approval with no video call required

Watch Out For

  • No published refund policy, address, email, named physicians, or named pharmacies
  • Unexplained multi-entity corporate structure (Oak/Flow/Mito Longevity Holdings)
  • Inconsistent self-reported patient counts (10,000+ vs 5,000+)
  • Thin early Trustpilot record (~4.0 stars, ~46 reviews)
  • Questionnaire-only, no-video prescribing puts screening weight on self-report
  • Compounded medications are not FDA-approved finished products; 2026 FDA compounding restrictions apply

Pricing Breakdown

Starting Price
Compounded semaglutide as low as $119/month—flat at every dosage
Medication Cost
Compounded tirzepatide as low as $185/month; NAD+, glutathione, tadalafil, and sermorelin priced separately
Subscription Fees
None—no subscription or membership fees; free shipping and health coaching included; $200 new-patient offer
Hidden Fees
None advertised, but no refund policy is published—get terms in writing before ordering

Safety & Medical Oversight

Oak medication safety
Oak requires a doctor's review of your health questionnaire before prescribing, with same-day approval and no video call—convenient, but disclose your full history carefully since questionnaire-only screening depends on it. Its pharmacies are described as licensed U.S. compounding pharmacies but are not named—ask which fills your prescription. Compounded semaglutide and tirzepatide are not FDA-approved finished products. GLP-1s are contraindicated with a personal or family history of medullary thyroid carcinoma or MEN 2. Sermorelin and NAD+ carry limited clinical evidence for their marketed benefits.

Customer Support

Phone: 435-244-7757. No email or address published; LegitScript badge displayed (confirm in the checker). Free health coaching included with plans. Keep purchase records—no refund policy is published.

Key Features

Compounded Semaglutide (From $119/mo)
Compounded Tirzepatide (From $185/mo)
Flat Price at Every Dosage
No Subscription or Membership
Free Shipping & Health Coaching
$200 New-Patient Offer
Same-Day Approval, No Video Call
NAD+, Glutathione, Tadalafil & Sermorelin Catalog

Best For

Cash-pay buyers who want flat, commitment-free GLP-1 pricing—and who confirm the billing entity, dispensing pharmacy, and refund terms in writing before ordering

Customer Reviews & Complaints

Our team reviewed available customer feedback for Oak (oaklovesyou.com) as of July 2026.

Trustpilot: Oak's profile is real but early—roughly 4.0 stars across about 46 reviews. Individual reviewers praise the quick, easy application, rapid delivery, good prices, and weight loss results (one citing 15 lbs over 4 months). The volume is too thin for firm conclusions; check the live profile as it grows.

Self-Reported Figures: The site's own claims are inconsistent—"10,000+ satisfied patients" and "trusted by 5,000+ members" both appear—so treat patient-count marketing as unverified.

What We'd Watch: With no published refund policy and an unexplained multi-entity corporate footer, the early questions to settle are billing mechanics: which entity charges you, what appears on your statement, and what happens if you need to return or dispute an order.

Overall Assessment: No complaint pattern exists yet. The no-subscription model structurally avoids the cancellation traps common to this category—Oak's biggest consumer-terms advantage—but get the refund terms in writing since they aren't published.

Is Oak Legit?

A common question about newer providers is: "Is Oak legit?" Here's our assessment as of July 2026.

Official Verification: Oak is a 2026-launched telehealth brand operating at oaklovesyou.com with a published phone line, a LegitScript badge (confirm in the public checker), doctor review before prescribing, and a small but real Trustpilot record. Its legal footer names multiple entities—Oak Longevity Holdings Corp., Flow Longevity Holdings Corp., and Mito Health Holdings Corp.—without explaining the relationships.

Licensing & Accreditation: Medications come from licensed U.S. compounding pharmacies, unnamed on the site—ask which fills your prescription and verify the prescribing clinician's license. Compounded semaglutide and tirzepatide are not FDA-approved finished products.

Red Flags Check: We looked for common warning signs:

  • ✓ Doctor review required; LegitScript badge displayed
  • ✓ Flat published pricing with no subscription mechanics
  • ✓ Published phone line; real early Trustpilot record
  • ⚠ No refund policy, address, email, named physicians, or named pharmacies published
  • ⚠ Unexplained multi-entity corporate structure
  • ⚠ Inconsistent self-reported patient counts
  • ⚠ Questionnaire-only same-day prescribing

Scam Assessment: We found no evidence Oak is a scam—the early customer record is positive and the pricing model is genuinely consumer-friendly. The cautions are transparency gaps typical of a young brand: resolve them in writing before paying.

The Bottom Line: Oak's flat, commitment-free pricing is one of the cleaner consumer propositions among new GLP-1 services—wrapped in a corporate presentation that needs a few direct answers. Confirm the billing entity, pharmacy, and refund terms, and as always, consult your personal physician before starting any new medication program.

Contact Information

Phone
435-244-7757

Our Verdict: Under Watch

After our comprehensive investigation, Oak receives a 7.5/10 rating. While this provider meets basic standards, there are some areas for improvement. Consider comparing with our top-rated options before making a decision.

Visit Oak
Our #1 Recommendation

CoreAge Rx

Verified Safe
9.9/10

Our highest-rated GLP-1 weight loss program

Visit CoreAge RxRead Our CoreAge Rx Review

Oak

Under Watch
7.5/10

Semaglutide from $119/mo; tirzepatide from $185/mo—flat all-dosage, no subscription

Visit Oak
FDA-approved medications

Investigation Summary

Overall Rank#102 of 107
Rating7.5/10
StatusUnder Watch
PricingSemaglutide from $119/mo; tirzepatide from $185/mo—flat all-dosage, no subscription

Share Your Experience

Help others by sharing your experience with Oak

Want to compare options?

View All 107 Providers

User Reviews

Rating Summary

No ratings yet

Rate your experience

Click a star to rate and add a review

Questions & Discussions

59 Providers Reviewed

Explore Other Reviews

Compare with other GLP-1 weight loss providers we've investigated

Our Top Picks

#1 RecommendedExcellent

CoreAge Rx

9.9

Premium GLP-1 Weight Loss Program with Personalized Medical Care

#2 RecommendedGreat

Mochi Health

8.8

Affordable GLP-1 Access Starting at $99/Month with No Long-Term Commitment

#3 RecommendedGreat

Ro

8.3

The Brand-Name GLP-1 Route: FDA-Approved Medications Only, with Insurance Concierge Support

Background
Under Watch

Ready to Get Started with Oak?

Review our findings above and make an informed decision about Oak.